PuSH - Publication Server of Helmholtz Zentrum München

Jesinghaus, M.* ; Boxberg, M.* ; Wilhelm, D.* ; Münch, S.* ; Dapper, H.* ; Quante, M.* ; Schlag, C.* ; Lange, S.* ; Budczies, J.* ; Konukiewitz, B.* ; Mollenhauer, M.* ; Schlitter, A.M.* ; Becker, K.F.* ; Feith, M.* ; Friess, H.* ; Steiger, K.* ; Combs, S.E. ; Weichert, W.*

Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma.

Br. J. Cancer 121, 1050-1057 (2019)
Publ. Version/Full Text Research data DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
BACKGROUND: Cellular Dissociation Grade (CDG) composed of tumour budding and cell nest size has been shown to independently predict prognosis in pre-therapeutic biopsies and primary resections of oesophageal squamous cell carcinoma (ESCC). Here, we aimed to evaluate the prognostic impact of CDG in ESCC after neoadjuvant therapy.METHODS: We evaluated cell nest size and tumour budding activity in 122 post-neoadjuvant ESCC resections, correlated the results with tumour regression groups and patient survival and compared the results with data from primary resected cases as well as pre-therapeutic biopsies.RESULTS: CDG remained stable when results from pre-therapeutic biopsies and post-therapeutic resections from the same patient were compared. CDG was associated with therapy response and a strong predictor of overall, disease-specific (DSS) and disease-free (DFS) survival in univariate analysis and-besides metastasis-remained the only significant survival predictor for DSS and DFS in multivariate analysis. Multivariate DFS hazard ratios reached 3.3 for CDG-G2 and 4.9 for CDG-G3 neoplasms compared with CDG-G1 carcinomas (p = 0.016).CONCLUSIONS: CDG is the only morphology-based grading algorithm published to date, which in concert with regression grading, is able to contribute relevant prognostic information in the post-neoadjuvant setting of ESCC.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.416
1.654
2
7
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Useful Prognostic Marker; Phase-iii Trial; Predicts Prognosis; Surgery; Cancer; Chemoradiotherapy; Chemotherapy; Radiotherapy; Regression; Features
Language english
Publication Year 2019
HGF-reported in Year 2019
ISSN (print) / ISBN 0007-0920
e-ISSN 1532-1827
Quellenangaben Volume: 121, Issue: 12, Pages: 1050-1057 Article Number: , Supplement: ,
Publisher Nature Publishing Group
Publishing Place Macmillan Building, 4 Crinan St, London N1 9xw, England
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Radiation Sciences
PSP Element(s) G-501300-001
Scopus ID 85074753050
PubMed ID 31690830
Erfassungsdatum 2019-11-14